Event Waitlist

Sorry, there are no available tickets for this event. Please sign up to the waiting list (optional).

First name is required. First name contains invalid characters.
Last name is required. Last name contains invalid characters.
Email address is required. Email address is invalid.
Phone number is required. Phone number is invalid.
Number of tickets is required. Number of tickets is invalid.

Your name has been added to the wait list for this event. The event organiser will contact you through your email address once there are available seats / slots.

This event has no dates available for booking. Please contact the event organiser.

Asthma and COPD Intensive - Albury

Asthma & COPD Intensive

Albury -  Tuesday 8th August 2017 

The Lung Health Promotion Centre is pleased to present a one day regional intensive health professionals in Mildura on Monday 24th July.


This busy day examines the latest Asthma and COPD essentials in a fast moving, interactive format.

Based on delegate preferences, session will be tailed to ensure presentation relevance, focusing on core learnings, advances and topical interests.


Presented by the experienced team at the Lung Health Promotion Centre the day promises to be essential day of your learning calendar.


Leaarning Outcomes

Explain the pathophysiology, diagnosis and management of asthma

Explain the pathophysiology, diagnosis and management of COPD

Differentiate asthma and COPD in clinical practice and how this would affect management

Use current guidelines to appropriately manage asthma and COPD

Discuss the devices for asthma and COPD treatments

Review current Smoking Cessation-effective support/use of NRT

Program Details:

Date: Tuesday 8th August

Time: 8:30 am registration for 9:00 am start

Venue: Best Western Plus - Hovell  Tree Inn

           614 Hovell Street, Albury NSW 2640

Cost $ 20 (Inc. GST) CPD = 7Hrs

Morning Tea and refreshments provided

Pre and post session review and session overview provided



03 9076 2382


This educational activity is supported by an independent educational grant from GlaxoSmithKline Australia.